Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis
Breast Cancer Research and Treatment · 2025-01 · 209 (2) · 229-252
DOI: 10.1007/s10549-024-07566-6 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 14.12.2024. Verfasst von Goran A Ahmed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Frimley Park Hospital, Frimley Health NHS Foundation Trust, Camberley, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NIHR Cambridge Biomedical Research Centre, Addenbrooke's Charitable Trust, Cambridge University Hospitals, NIHR.
Abstract (Originalsprache)
PURPOSE: Oncoplastic breast-conserving surgery (OBCS) prevents compromise of breast aesthetics following large breast cancer excisions. This systematic review was conducted to investigate the outcomes (oncologic, surgical, cosmetic) of OBCS versus standard breast-conserving surgery (SBCS) and mastectomy post-neo-adjuvant systemic therapy. METHODS: Ovid, Web of Science, Cochrane, ClinicalTrials.gov databases were searched up to 24/08/2024. English language peer-reviewed RCTs or observational/cohort studies with ≥ 18-year-old women treated for breast cancer with neoadjuvant chemotherapy (NACT) and/or hormonal therapy comparing OBCS to SBCS and/or mastectomy were included. Of 6794 articles, 32 underwent full-text assessment and eleven met the inclusion criteria. The review was conducted using PRISMA guidelines. Two reviewers independently extracted data and assessed risk of bias (Newcastle-Ottowa Scale). Meta-analysis using a random-effects model were performed where data allowed. RESULTS: Eleven cohort studies (n = 4594) included OBCS (n = 912), SBCS (n = 1122) and mastectomy (n = 2560) after NACT. Post-NACT tumour size was 20(9-44) mm, 13(0-23)mm [SMD 0.62, 95%CI(-0.24,1.48), p = 0.16] and 20(10-31)mm [SMD 0.05, 95%CI(-0.53,0.63), p = 0.86] in the OBCS, SBCS and mastectomy groups respectively. The margin re-excision rate was significantly lower in OBCS than in SBCS [2.9%(0-11.1%) vs. 6.1%(0-18.5%); OR 0.35, 95%CI(0.15,0.80), p = 0.01]. All other oncologic outcomes, including positive margin rate, and overall survival, were not statistically different between the groups. Cosmetic outcomes and patient-reported outcome measures were marginally in favour of OBCS [OBCS 50-66% vs SBCS 37.6-55% very satisfied]. CONCLUSION: OBCS after NACT appears oncologically safe and a potential alternative in patients with partial or poor tumour response to NACT. Further studies are required, directly comparing well-matched OBCS with SBCS and mastectomy patients after NACT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Frimley Park Hospital, Frimley Health NHS Foundation Trust, Camberley, UK.
- John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK. daniel.baron1@nhs.net.
- University of Oxford, Oxford, UK. daniel.baron1@nhs.net.
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- University of Cambridge, Cambridge, UK.
Förderung
- NIHR Cambridge Biomedical Research Centre
- Addenbrooke's Charitable Trust, Cambridge University Hospitals
- NIHR
- UK Research and Innovation
Zitieren
APA
Ahmed, G. A., Baron, D. H., & Agrawal, A. (2025). Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis. Breast Cancer Research and Treatment, 209(2), 229-252. https://doi.org/10.1007/s10549-024-07566-6
Vancouver
Ahmed GA, Baron DH, Agrawal A. Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis. Breast Cancer Research and Treatment. 2025;209(2):229-252. doi:10.1007/s10549-024-07566-6
BibTeX
@article{Ahmed2025,
author = {Ahmed, Goran A and Baron, Daniel H and Agrawal, Amit},
title = {Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis},
journal = {Breast Cancer Research and Treatment},
year = {2025},
volume = {209},
number = {2},
pages = {229--252},
doi = {10.1007/s10549-024-07566-6}
}
EUVIMED